MA34643B1 - Composant comprenant du 2-méthylpropanethioate de s-[2-([[1-(2-éthylbutyl)-cyclohexyl]-carbonyl]amino)phényle] et de la croscarmellose sodique - Google Patents
Composant comprenant du 2-méthylpropanethioate de s-[2-([[1-(2-éthylbutyl)-cyclohexyl]-carbonyl]amino)phényle] et de la croscarmellose sodiqueInfo
- Publication number
- MA34643B1 MA34643B1 MA35868A MA35868A MA34643B1 MA 34643 B1 MA34643 B1 MA 34643B1 MA 35868 A MA35868 A MA 35868A MA 35868 A MA35868 A MA 35868A MA 34643 B1 MA34643 B1 MA 34643B1
- Authority
- MA
- Morocco
- Prior art keywords
- methylpropanethioate
- ethylbutyl
- cyclohexyl
- carbonyl
- croscarmellosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne une composition contenant : a) du 2-méthylpropanethioate de S-[2-([[1-(2-éthylbutyl)cyclohexyl]carbonyl]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10190045 | 2010-11-04 | ||
| PCT/EP2011/069087 WO2012059447A1 (fr) | 2010-11-04 | 2011-10-31 | Composant comprenant du 2-méthylpropanethioate de s-[2-([[1-(2-éthylbutyl)-cyclohexyl]-carbonyl]amino)phényle] et de la croscarmellose sodique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA34643B1 true MA34643B1 (fr) | 2013-11-02 |
Family
ID=43759428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA35868A MA34643B1 (fr) | 2010-11-04 | 2013-05-03 | Composant comprenant du 2-méthylpropanethioate de s-[2-([[1-(2-éthylbutyl)-cyclohexyl]-carbonyl]amino)phényle] et de la croscarmellose sodique |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9107836B2 (fr) |
| EP (1) | EP2635263B1 (fr) |
| JP (1) | JP5676005B2 (fr) |
| KR (1) | KR101579659B1 (fr) |
| CN (2) | CN105833283A (fr) |
| AR (1) | AR083693A1 (fr) |
| BR (1) | BR112013010704B8 (fr) |
| CA (1) | CA2815280C (fr) |
| CL (1) | CL2013001164A1 (fr) |
| CR (1) | CR20130181A (fr) |
| EA (1) | EA025649B1 (fr) |
| EC (1) | ECSP13012603A (fr) |
| ES (1) | ES2553279T3 (fr) |
| IL (1) | IL225780B (fr) |
| MA (1) | MA34643B1 (fr) |
| MX (1) | MX345650B (fr) |
| MY (1) | MY164729A (fr) |
| NZ (1) | NZ609529A (fr) |
| PE (1) | PE20140018A1 (fr) |
| SG (1) | SG190025A1 (fr) |
| TW (1) | TWI507192B (fr) |
| UA (1) | UA110117C2 (fr) |
| WO (1) | WO2012059447A1 (fr) |
| ZA (1) | ZA201302954B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010213899B2 (en) | 2009-02-10 | 2014-02-06 | Amarin Pharmaceuticals Ireland Limited | Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia |
| KR102153557B1 (ko) | 2013-03-27 | 2020-09-09 | 에프. 호프만-라 로슈 아게 | 치료에 대한 반응성을 예측하기 위한 유전 마커 |
| JP5871984B2 (ja) * | 2013-04-15 | 2016-03-01 | 株式会社三和化学研究所 | オルメサルタンメドキソミルを含有する医薬組成物 |
| EP3524238A1 (fr) | 2013-12-19 | 2019-08-14 | F. Hoffmann-La Roche AG | Modulateur cetp destiné à être utilisé dans le traitement de maladies oculaires |
| WO2016016157A1 (fr) | 2014-07-30 | 2016-02-04 | F. Hoffmann-La Roche Ag | Marqueurs génétiques pour la prédiction de la réactivité à une thérapie avec un agent d'augmentation de hdl ou d'imitation de hdl |
| CN104434913A (zh) * | 2014-12-20 | 2015-03-25 | 长沙佰顺生物科技有限公司 | 一种安塞曲匹药物组合物及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2894445B2 (ja) | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Ｃｅｔｐ活性阻害剤として有効な化合物 |
| US7208465B2 (en) * | 2000-11-03 | 2007-04-24 | The Procter & Gamble Company | Methods and compositions for improved fragrancing of a surface |
| DE60319877T2 (de) * | 2002-12-20 | 2009-04-30 | Pfizer Products Inc., Groton | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
| PT1603553E (pt) | 2003-03-17 | 2012-02-03 | Japan Tobacco Inc | Composições farmacêuticas de inibidores de cetp |
| JP2006520810A (ja) | 2003-03-17 | 2006-09-14 | 日本たばこ産業株式会社 | Ｓ−［２−（［［１−（２−エチルブチル）シクロヘキシル］カルボニル］アミノ）フェニル］２−メチルプロパンチオエートの経口吸収性を増加させる方法 |
| AU2004261058A1 (en) * | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of HMG-CoA reductase inhibitors |
| CA2596240A1 (fr) | 2005-01-28 | 2006-08-03 | Pfizer Products Inc. | Liants microporeux a desintegration rapide |
| US7435849B2 (en) | 2005-10-31 | 2008-10-14 | Hoffmann-La Roche Inc. | Process for the production of acid chlorides |
| EP1935867A1 (fr) | 2006-12-20 | 2008-06-25 | F. Hoffmann-La Roche Ag | Procédé de préparation de l'acide 1-(2-éthyl-butyl)-cyclohexanecarboxylique |
| EP2373344B1 (fr) * | 2008-12-08 | 2016-03-30 | F. Hoffmann-La Roche AG | Administration conjointe |
| US20110004011A1 (en) | 2009-07-01 | 2011-01-06 | Declan Costello | Novel process |
-
2011
- 2011-10-31 PE PE2013000910A patent/PE20140018A1/es not_active Application Discontinuation
- 2011-10-31 UA UAA201306203A patent/UA110117C2/uk unknown
- 2011-10-31 ES ES11776201.3T patent/ES2553279T3/es active Active
- 2011-10-31 NZ NZ609529A patent/NZ609529A/en unknown
- 2011-10-31 CN CN201610309140.6A patent/CN105833283A/zh active Pending
- 2011-10-31 CA CA2815280A patent/CA2815280C/fr active Active
- 2011-10-31 SG SG2013032123A patent/SG190025A1/en unknown
- 2011-10-31 BR BR112013010704A patent/BR112013010704B8/pt active IP Right Grant
- 2011-10-31 WO PCT/EP2011/069087 patent/WO2012059447A1/fr active Application Filing
- 2011-10-31 EA EA201390622A patent/EA025649B1/ru not_active IP Right Cessation
- 2011-10-31 KR KR1020137014214A patent/KR101579659B1/ko active IP Right Grant
- 2011-10-31 MX MX2013004584A patent/MX345650B/es active IP Right Grant
- 2011-10-31 EP EP11776201.3A patent/EP2635263B1/fr active Active
- 2011-10-31 MY MYPI2013700710A patent/MY164729A/en unknown
- 2011-10-31 CN CN2011800532370A patent/CN103200935A/zh active Pending
- 2011-10-31 JP JP2013537093A patent/JP5676005B2/ja active Active
- 2011-11-03 AR ARP110104077A patent/AR083693A1/es unknown
- 2011-11-03 TW TW100140194A patent/TWI507192B/zh not_active IP Right Cessation
- 2011-11-03 US US13/288,082 patent/US9107836B2/en active Active
-
2013
- 2013-04-15 IL IL225780A patent/IL225780B/en active IP Right Grant
- 2013-04-23 ZA ZA2013/02954A patent/ZA201302954B/en unknown
- 2013-04-24 CR CR20130181A patent/CR20130181A/es unknown
- 2013-04-29 CL CL2013001164A patent/CL2013001164A1/es unknown
- 2013-05-03 MA MA35868A patent/MA34643B1/fr unknown
- 2013-05-03 EC ECSP13012603 patent/ECSP13012603A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA34643B1 (fr) | Composant comprenant du 2-méthylpropanethioate de s-[2-([[1-(2-éthylbutyl)-cyclohexyl]-carbonyl]amino)phényle] et de la croscarmellose sodique | |
| PH12017502300A1 (en) | Pesticidal compositions and processes related thereto | |
| PH12014502397B1 (en) | Pesticidal compositions and processes related thereto | |
| MA35280B1 (fr) | Inhibiteurs de l'activation des lymphocytes t | |
| MA35402B1 (fr) | Compositions pesticides et procédés associés | |
| CO6680675A2 (es) | Tidiazoles substituidos y composiciones pesticidas que los contienen | |
| ATE515497T1 (de) | Insektizide n-substituierte (6-haloalkylpyridin-3-yl)alkyl-sulfoximine | |
| BRPI1014543B8 (pt) | Moléculas e composições pesticidas | |
| ITMO20060222A1 (it) | Pacchetto di medicazione antiemorragico | |
| DE602006019234D1 (de) | Augenoptische einrichtungen für aufrechterhaltene abgabe aktiver zusammensetzungen | |
| EP2074745A4 (fr) | Identification de source active pour conférences téléphoniques | |
| MX2016000307A (es) | Farmaco para el tratamiento de la esteatosis hepatica no alcoholica. | |
| MX355431B (es) | Composiciones plaguicidas y procesos relacionados con dichas composiciones. | |
| SM201000108B (it) | Composti e composizioni come inibitori di proteinachinasi | |
| SMAP200900020A (it) | Composti e composizioni come inibitori di proteinachinasi | |
| UA109924C2 (uk) | Аміди аміноінданів, які мають високу фунгіцидну активність та їх фітосанітарна композиція | |
| MA28545B1 (fr) | Amides tri (cyclo) substitués | |
| FR2930081B1 (fr) | Garniture d'etancheite pour connecteur | |
| BRPI0716765A2 (pt) | mÉtodos e composiÇÕes para administrar agentes hipoglicÊmicos de longa duraÇço | |
| FR2968032B1 (fr) | Ensemble d'etancheite pour turbomachine | |
| SG158091A1 (en) | Imidazoazepinone compounds | |
| FR2950232B1 (fr) | Ensemble de conditionnement et d'application cosmetique pour compositions rheofluidifiantes | |
| BRPI0815303A2 (pt) | "componenete elástico para uma vestimenta com vedação melhorada" | |
| MX2013006031A (es) | Formulacion liposomal de dalcetrapib. | |
| ITTO20060082U1 (it) | Unita' per l'applicazione di dispositivi di apertura su confezioni di prodotti alimentari versabili |